Mount Sinai
Linus Biotechnology Raises $16M in Series A Funding
The Mount Sinai spinout will use the funds to advance its StrandDx platform, correlating environmental exposures to biological responses.
Gene Signature Reflects Host Response to COVID-19 Infections With Low Cross-Reactivity
The researchers established a framework to generate robust host infection response signatures with the aim of improving diagnostic sensitivity.
Long COVID Clues Found in Acute SARS-CoV-2 Infection Blood Samples
With RNA sequencing of acute infection samples from hospitalized COVID-19 patients, researchers narrowed in on expression patterns linked to disease sequalae.
Neuropsychiatric Disease Clues Drawn From Enhancer Expression Analysis
Researchers investigated the variation in enhancer expression within a population, using the clues to better understand the risk of neuropsychiatric conditions such as schizophrenia.
While Regeneron has more than 100 other sequencing collaborations, including with All of Us and UK Biobank, none approaches the scale of its new plans with Mount Sinai Health System.